TSHA 8-K 2026-06-25

Taysha Gene Therapies, Inc. (TSHA) 8-K dated 2026-06-25 — accession 0001193125-26-282855. This URL is the filing, not the TSHA hub.

Taysha Gene Therapies, Inc. (TSHA) is a biotechnology company listed on US.

Taysha Gene Therapies, Inc. filed a 8-K on 2026-06-25. Accession 0001193125-26-282855.

Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TSHA revenue for 2025-12-31 was $9.8M. Net income was -$109.0M. Revenue was up 17.3% from 2024-12-31 to 2025-12-31. TSHA currently screens at market cap $640.7M.

Not investment advice. The TSHA SEC hub lists recent forms. The stock page is the research view.